KFDA approved Daewoong's EGF, a new drug for diabetic ulcer.

Published: 2001-06-04 06:59:00

Updated: 2001-06-04 06:59:00

The KFDA authorized to manufacture the first new diabetic ulcer drug on May 30, of which Daewoong pharmaceutical company developed for the first in its high quality, purity and closer to the human molecular over the world through a bio-engineering technology.

EGF (epidermal growth factor) is f...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK